Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep706 | Obesity | ECE2017

Folate: a new player in metabolic syndrome?

Paredes Silvia , Alves Marta , Pereira Maria Lopes , da Costa Jose Maia , Fernandes Aline , Manso Fernando , Marques Olinda , Ribeiro Laura

Introduction: Bariatric surgery (BS) candidates display several nutritional deficiencies that can aggravate after surgery. Metabolic syndrome (MS) is a cluster of cardiovascular risk factors with several disturbed metabolic pathways. Therefore, individuals with MS submitted to BS are probably more prone to nutritional deficiencies.Objective: To evaluate the prevalence of nutritional deficiencies and eventual differences between BS candidates with and wit...

ea0049ep707 | Obesity | ECE2017

Evolution of body composition 3 years after sleeve gastrectomy

Paredes Silvia , Alves Marta , Pereira Maria Lopes , da Costa Jose Maia , Fernandes Aline , Manso Fernando , Marques Olinda , Ribeiro Laura

Background: Sleeve gastrectomy (SG) has effective results on weight loss, which should result from fat mass loss and efforts should be made to preserve lean mass. Few studies have evaluated body composition (BC) changes after SG for periods >2 years.Objective: To investigate the impact of SG on weight and BC, comparing by gender.Materials and methods: Retrospectively, databases of patients who underwent SG between 2011 and 2013...

ea0070ep265 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Diabetic gastroparesis as an important comorbidity factor: About a clinical case

Veríssimo David , Faustino Diogo , Lopes da Costa Inês , Pires Pedro , Marques Carmen , Almeida Júlio

Introduction: Gastroparesis associated with diabetic autonomic neuropathy is an underdiagnosed complication, although relatively common in diabetes. It is more prevalent in type 1 Diabetes Mellitus (DM1) with more than ten years of disease and especially in patients with poor metabolic control.Clinical case: Female, 37 years old, DM1 with 17 years of evolution with poor metabolic control (HbA1c 9.3%) and several microvascular complications such as prolif...